glp-1 anesthesia guidelines 2025 RA guidance roundup Weight Loss Medications Before Surgery

[DOI] [PubMed] [Google Scholar] 67.Stark J, Klass MJ, Owen L

You should consult a healthcare provider if you are unsure about your current dose escalation step, experiencing persistent side effects, transitioning between different semaglutide products, combining semaglutide with other peptide stacks , or have underlying conditions that might affect how you metabolize the medication

standard deviation [SD], 3.5 years

adult obesity rate has gradually dropped to 36.4% thus far in 2026, a statistically meaningful decline that continues to inversely track with increased usage of GLP-1 medicine nationally

Strengthen your foundation